Carle Illinois College of Medicine seeks to maintain a campus environment that is free of the illegal use of alcohol and other drugs and in compliance with applicable federal, state, and local laws. Hospitals, health care systems, and clinical training sites critical to the student’s medical education may have policies requiring drug testing.


Accepted Applicant or Acceptee: A person who has applied to Carle Illinois College of Medicine and has been offered conditional admission.

Matriculant: Any accepted applicant who has attended the Carle Illinois College of Medicine orientation, for their most recent matriculation year, immediately preceding enrollment in the first credit-bearing course of the curriculum.

Student: A person currently enrolled and attending Carle Illinois College of Medicine courses and for whom the University of Illinois maintains an academic record.

10-Panel Urine Drug Panel Testing: The 10-panel drug screen targets amphetamines/methamphetamines, cocaine, cannabis, opiates, phencyclidine, propoxyphene, barbiturates, benzodiazepines, methadone and methaqualone.

CI MED designated Medical Review Officer (MRO): Medical Review Officer ensures security, data protection, compliance, and procedural handling of positive screens.

Policy: Carle Illinois College of Medicine requires a 10-panel drug test prior to matriculation into the program. Results of the 10-panel drug test should be received one week prior to the start of Orientation Week. Any unexcused non-negative or positive test may result in an accepted applicant’s offer of admission being rescinded.

Additionally, the Associate Dean for Student Affairs may require a student to submit to a drug test at any time “for cause,” based upon:

  • Reasonable suspicion of substance abuse;
  • Unauthorized use or possession of illegal drugs, alcohol, cannabis on campus or in a health care setting; or
  • Use or possession of illicit drugs at any time;

“Reasonable suspicion of substance abuse” may be based upon, but is not limited to, the following criteria:

  • Direct observation of the student’s behavior consistent with the use of illegal drugs, alcohol, or cannabis;
  • A reliable report of illegal drug, alcohol, or cannabis use provided by a credible source that has been corroborated by the Associate Dean of Student Affairs;
  • The student is believed to pose a risk to self or others;
  • The student is involved in an accident or incident that results in potential harm or actual harm to another person; or
  • Change in behavior such as absenteeism, tardiness, or significant deterioration of

Students who refuse drug testing will be cited with being unprofessional behavior and refusal will delay starting or suspend clinical training. If students disagree with the decision, they may pursue the grievance policy outlined in the student handbook.

Additionally, in the interest of the student, drug test results may be shared with clinical training sites affiliated with the Carle Illinois College of Medicine to avoid the need for duplicate drug tests and to assure training sites that the student has complied with their drug testing policies. All drug test results and related information will be treated as confidential but may be shared in accordance with the student’s consent form and as otherwise required by law.

Although Illinois law allows for the use of medical cannabis and recreational cannabis in certain circumstances, federal laws prohibit cannabis use, possession, and distribution on property owned by institutions of higher education or in any activities operated by such institutions. In addition, Illinois law states that colleges and universities are not prevented from prohibiting cannabis, consistent with federal law. As such, the use, possession, and distribution of cannabis at the Carle Illinois College of Medicine (CI MED), elsewhere on the University of Illinois campuses (or other University property), or in connection with any part of the University’s educational or other activities, regardless of where those activities occur, remains prohibited. Moreover, in order to rotate at clinical sites, all CI MED students are bound by the policies and procedures of the clinical site, which may be more restrictive and forbid the use of certain substances even if that use is off-site or would otherwise be considered legal under state or local law (e.g., medical cannabis, cannabis for recreational use).

Procedure: Accepted Applicants will be responsible for securing a medical office/vendor to conduct their drug screening and are also responsible for payment of this service. The results will need to be uploaded and reported through a single-source, third party vendor, Certiphi Screening. The designated MRO will be responsible for reviewing the results and verifying compliance. will be asked to sign a consent form allowing the drug test and the release of test results to those with a need to know under this policy.

Testing Prior to Matriculation: Carle Illinois College of Medicine will provide each acceptee with information about the process to complete the required 10- panel drug screen in the onboarding information.

An accepted applicant who tests positive will have the opportunity to provide either a prescription or an explanation for the positive test result. The Associate Dean of Student Affairs will review each case involving a positive test result and it may result in their acceptance to Carle Illinois College of Medicine being rescinded.

An accepted applicant who refuses drug testing will be referred to the Associate Dean for Student Affairs. The Associate Dean of Student Affairs will review each case and it may result in their acceptance to Carle Illinois College of Medicine being rescinded.

Positive Drug Screen: If the specimen comes back to the MRO as NON-negative or positive, the MRO will call the accepted applicant and inquire regarding any medications prescribed by a physician for medical reasons. The MRO will inform the accepted applicant on how they can verify that they are on physician prescribed medications. If a medical explanation for use is approved by the MRO, the result will be changed to negative.

Drug Screen Result other than Positive or Negative: If the accepted applicant’s drug screen result is neither positive nor negative, then the test must be repeated (at the accepted applicant’s expense). A test result that is neither positive nor negative includes but is not limited to a Negative Dilute, Positive Dilute, Positive No Contact, or Cancelled specimen.

If an accepted applicant’s has a NON-negative drug screen, they may not be permitted to matriculate at CI MED. The accepted applicant may appeal to the Associate Dean for Student Affairs in writing prior to the first day of class. As part of the appeal, the accepted applicant will be able to explain the NON-negative result. A NON-negative result could result in a decision to rescind admission. Such decisions will be made on a case-by-case basis that considers an individualized assessment of the circumstances.

Testing After Matriculation: Students who are required to undergo drug testing for cause after matriculation must present to a mutually acceptable, third-party drug screen vendor that is independent of the University and the Carle Illinois College of Medicine’s clinical training affiliates.

Students who test positive may be subject to disciplinary sanctions and professional standards.  A violation of Carle Illinois professional standards and/or the University of Illinois student code will initiate the due process for the student.

Exceptions: None

Contact: Office of Student Affairs, 217-300-5700

Governing Body: Office of Student Affairs


Created: February 26, 2018

Revised: A. Jake – May 5, 2020 – Updated definitions of acceptees, matriculants, and students for consistency throughout CIMED policies. Process for completion also updated.

Approved By/Date:

Administrative-Office of Student Affairs, February 26, 2018
Executive Leadership Team, May 12, 2020